Exelixis reported $-31427000 in Pre-Tax Profit for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US USD -40890000 14.48M
Agios Pharmaceuticals AGIO:US USD 36.53M 118.27M
Akebia Therapeutics AKBA:US USD -7552000 44.31M
Amgen AMGN:US USD 2.54B 364M
AstraZeneca AZN:LN USD 2.29B 796M
Biomarin Pharmaceutical BMRN:US USD -17558000 15.65M
Bluebird Bio BLUE:US USD -76513000 16.99M
Cytokinetics CYTK:US USD -137380000 4.93M
Eisai 4523:JP JPY 9.46B 11.04B
Eli Lilly And LLY:US USD 2.04B 38.3M
Esperion Therapeutics ESPR:US USD -55487000 370K
Exelixis EXEL:US USD -31427000 123.47M
Genmab GEN:DC DKK 662M 2.61B
Glaxosmithkline GSK:US GBP 1.6B 409.03M
Immunogen IMGN:US USD -57790000 19.96M
Macrogenics MGNX:US USD 12.8M 37.61M
Merk MRK:US USD 4.89B 560M
Mirati Therapeutics MRTX:US USD -202221000 28.91M
Moderna Inc MRNA:US USD 1.66B 438M
Nektar Therapeutics NKTR:US USD -56544000 2.66M
Neurocrine Biosciences NBIX:US USD 117.9M 20M
Novartis NOVN:VX USD 3.86B 195M
Pfizer PFE:US USD 7.38B 3.3B
Puma Biotechnology PBYI:US USD -5300000 5.01M
Takeda 4502:JP JPY 107.15B 42.6B
Ultragenyx Pharmaceutical RARE:US USD -153284000 85.54M
Xencor XNCR:US USD -12457000 19.21M
YTE INCY:US USD 178.62M 401K